ATI-9242

· Braeburn Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ATI-9242, covering 2017-07-17 to 2017-07-17. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate D2 Receptor Occupancy Following Single Intravenous Administration of ATI-9242 [Phase 1]